$150.00 – $700.00
Lisdexamfetamine (Vyvanse belongs to a group of medications called stimulants. It is used to treat attention deficit hyperactivity disorder (AD/HD).
.Lisdexamfetamine is approved by Health Canada for treating AD/HD in adolescents and children age six and over. It is used to improve the mental and behavioral symptoms of AD/HD, which includes short attention span, impulsive behaviour, and hyperactivity. Lisdexamfetamine does not cure AD/HD. It aims to improve functioning by reducing core AD/HD symptoms such as the inability to pay attention, impulsive behaviour, and hyperactivity. Lisdexamfetamine improves core AD/HD symptoms in approximately three-quarters of children and adolescents. It can also help you tolerate frustration better and improve social and peer relationships.
Patients should be reviewed at least annually to assess if there is an ongoing requirement for treatment with VYVANSE. Blood pressure and cardiovascular status should also be regularly reviewed. VYVANSE should be administered orally at the lowest possible dosage and should then be slowly adjusted to the lowest effective dose for each individual. VYVANSE should be taken in the morning with or without food; avoid afternoon doses because of the potential for insomnia. VYVANSE capsules may be taken whole, or the capsule may be opened and the entire contents emptied and mixed in a glass of water.
Loss of appetite, weight loss (take the medication with breakfast, drink a smoothie or high protein drink or Boost at lunch, and have a major meal when the medication wears off)
Trouble sleeping (try taking the last dose of the day at an earlier time; starting a bedtime routine; or try adding melatonin 3 – 6 mg taken 30 minutes before bedtime)
Nausea, vomiting, stomach aches (this is often a sign of hunger, try eating something)
Stuffy nose (try using a saline nasal spray)
Fast heart rate .
Irritability, agitation, energized feelings, nervousness (avoid caffeine from colas, coffee, or tea)
VYVANSE is contraindicated in patients with; · Advanced arteriosclerosis · Symptomatic cardiovascular disease including cardiac arrhythmia, ischaemic heart disease · Moderate to severe hypertension · Hyperthyroidism · Known hypersensitivity to sympathomimetic amines or any of the excipients · Glaucoma · Agitated states such as severe anxiety, tension and agitation · During or within 14 days following the administration of monoamine oxidase inhibitors (hypertensive crises may result) ·
120 Pills, 180 Pills, 230 Pills, 500 Pills, 90 Pills